Unique ID issued by UMIN | UMIN000003099 |
---|---|
Receipt number | R000003324 |
Scientific Title | The influence of glucose administration during surgery on the postoperative glucose metabolism in the patients undergoing elective laparoscopic gastrectomy |
Date of disclosure of the study information | 2010/01/27 |
Last modified on | 2010/01/27 07:17:24 |
The influence of glucose administration during surgery on the postoperative glucose metabolism in the patients undergoing elective laparoscopic gastrectomy
The influence of glucose administration during surgery on the postoperative glucose metabolism
The influence of glucose administration during surgery on the postoperative glucose metabolism in the patients undergoing elective laparoscopic gastrectomy
The influence of glucose administration during surgery on the postoperative glucose metabolism
Japan |
Malignant tumor of stomach
Gastrointestinal surgery | Anesthesiology | Operative medicine |
Malignancy
NO
The influence of intraoperative glucose administration on the postoperative glucose metabolism is investigated in the elective- laparoscopic gastrectomy patients randomly assigned to the group administered the extracellular fluid replacement solution containing 1% glucose or the group administered such solution without glucose.
Efficacy
Postoperative glucose metabolism evaluated by the insulin resistance (HOMA-IR) calculated by the following equation:
HOMA-IR= serum glucose level (mg/dL) x serum insulin level (micro U/mL )/405
The values are measured in early morning of the day following the surgery.
1. Intraoperative glucose tolerance (serum glucose, insulin, and C-peptide)
2. Intraoperative protein metabolism (urinary 3-methyhistidine)
3. Intraoperative fat metabolism (serum free fatty acid and ketone bodies)
The values are measured every 2 hours during the surgery.
Interventional
Parallel
Randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
An extracellular fluid replacement solution containing 1% glucose is administered during surgery.
An extracellular fluid replacement solution without glucose is administered during surgery.
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients aged 20 years or older
2. Male patients or female patients
3. Patients in ASA category I to II
4. Patients who provide informed consent before registration
1. Patients with hypermagnesemia
2. Patients with hypothyroidism
3. Diabetic patients, patients with abnormal glucose tolerance, and the patients with such disease histories
4. Patients with severe heart diseases
5. Patients with severe kidney dysfunction
6. Patients with severe liver dysfunction
7. Others who are deemed unsuitable for inclusion in the study for any other reason based on the assessment by the investigator
40
1st name | |
Middle name | |
Last name | Itsuo Nakatsuka |
Keio University Hospital
Anesthesiology
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
1st name | |
Middle name | |
Last name |
Keio University Hospital
Anesthesioloby
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
Department of Anesthesiology, Keio University School of Medicine
Department of Anesthesiology, Keio University School of Medicine
Other
NO
2010 | Year | 01 | Month | 27 | Day |
Unpublished
Enrolling by invitation
2009 | Year | 10 | Month | 27 | Day |
2009 | Year | 11 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2010 | Year | 01 | Month | 27 | Day |
2010 | Year | 01 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003324